Skip to main content

Table 2 Baseline Characteristics of All Patients from 2006 and 2013

From: Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience

Variable

2006 (N = 397)

2013 (N = 372)

P Value

Age

61 ± 17

63 ± 15

0.153

Male Sex n (%)

228 (57)

211 (57)

0.884

Location

  

<0.001

Cardiology

126 (32)

122 (33)

Coronary Care Unit

38 (10)

35 (9)

Medical/Surgical Ward

29 (7)

62 (17)

General Surgery

136 (34)

75 (20)

Internal Medicine

68 (17)

78 (21)

Medical Co-morbidities

   

Diabetes Mellitus

112 (28)

114 (31)

0.477

Hypertension

221 (56)

214 (58)

0.611

Atrial Fibrillation

41 (10)

69 (19)

0.001

Congestive Heart Failure

63 (16)

53 (14)

0.547

Ischemic Heart Disease

134 (34)

102 (27)

0.061

Chronic Obstructive Lung Disease

55 (14)

61 (16)

0.364

Malignancy

69 (17)

69 (19)

0.707

Liver Disease

19 (5)

24 (6)

0.348

Chronic Kidney Disease

100 (25)

92 (25)

0.934

(GFR < 60 ml/min/1.73 m2)

Alcohol Abuse

8 (2)

14 (4)

0.194

Gastrointestinal Symptoms

83 (21)

102 (27)

0.043

Surgery

96 (24)

87 (23)

0.865

Medications

   

Calcineurin Inhibitor

9 (2)

13 (3)

0.388

Diuretics

125 (31)

121 (33)

0.758

Proton Pump Inhibitors

100 (25)

130 (35)

0.004

Oral Magnesium

9 (2)

11 (3)

0.652

Laboratory mean (SD)

   

Calcium (Total) (n = 171/210)

2.17 (2.04-2.30)

2.10 (2.01-2.12)

0.002

Potassium (n = 396/369)

4.1 (3.8-4.5)

4.2 (3.8-4.5)

0.968

Hemoglobin (n = 396/371)

127 (111–143)

127 (108–140)

0.163

Albumin (n = 149/158)

30 (26–34)

30 (24–34)

0.649

MDRD GFR (396/266)

63 (42–81)

69 (45–88)

0.023

Magnesium (N = 173/233)

0.84 (0.75-0.92)

0.78 (0.71-0.86)

<0.001

Admission Magnesium Low (n = 173/233)

39 (23)

76 (33)

0.030